Genetic disease risk screening is becoming a popular employee benefit. But the tests may not be all that beneficial for the general population, experts say.

Genetic disease risk screening is becoming a popular employee benefit. But the tests may not be all that beneficial for the general population, experts say. https://ift.tt/2H1RfQ9 The New York Times Genetic disease risk screening is becoming a popular employee benefit. But the tests may not be all that beneficial for the general population, experts say. https://ift.tt/2vkhksw Genetic disease risk screening is becoming a popular employee benefit. But the tests may not be all that beneficial for the general population, experts say.
By NATASHA SINGER from NYT Technology https://ift.tt/2vkhksw
via
IFTTT